Dupixent (Dupilumab) Insurance Denial Appeal Guide

Dupixent (dupilumab) is a biologic treatment for moderate-to-severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, and prurigo nodularis. Despite FDA approval for multiple conditions, insurers frequently require extensive step therapy before approval.

FDA-Approved Indications

  • Moderate-to-severe atopic dermatitis (age 6 months+)
  • Moderate-to-severe asthma (age 6+)
  • Chronic rhinosinusitis with nasal polyps (adults)
  • Eosinophilic esophagitis (age 1+, weight 15kg+)
  • Prurigo nodularis (adults)

Common Step Therapy Requirements

Insurers typically require failing:
  • Topical corticosteroids (high potency)
  • Topical calcineurin inhibitors (tacrolimus, pimecrolimus)
  • Phototherapy
  • Systemic immunosuppressants (methotrexate, cyclosporine, mycophenolate)

Appeal Strategy

  1. Document severity — EASI score, BSA involvement, quality of life impact (DLQI)
  2. Photo documentation of affected areas
  3. List all failed prior treatments with dates and outcomes
  4. Dermatologist or allergist letter of medical necessity
  5. Cite clinical guidelines (AAD, AAAAI)
  6. Note that systemic immunosuppressants carry significant toxicity risks
  7. For children, emphasize that systemic immunosuppressants are particularly risky

Key Clinical Evidence

  • SOLO 1 & 2 trials: 36-38% achieved clear/almost clear skin (EASI-75)
  • LIBERTY AD CHRONOS: Long-term efficacy data
  • No immunosuppression — Dupixent works via IL-4/IL-13 pathway, not broad immunosuppression

Detailed Guides

Appealing Dupixent Pediatric Coverage Denials

How to appeal Dupixent denials for children with eczema or asthma. FDA-approved indications, pediatric documentation, and appeal strategies.

Need Help Writing Your Appeal?

Our AI-powered tool analyzes your denial letter and generates a personalized appeal in minutes. Upload your denial and get started for free.

Start Your Free Appeal

Frequently Asked Questions

How much does Dupixent cost without insurance?

Dupixent costs approximately $3,500-$4,000 per month without insurance. Sanofi/Regeneron offers a copay card for commercially insured patients (as low as $0 copay) and a patient assistance program for uninsured patients.

How long does Dupixent prior authorization take?

Standard prior authorization for Dupixent typically takes 5-14 days. Urgent requests may be expedited to 72 hours. If denied, you typically have 180 days to file an appeal. Your prescriber can request a peer-to-peer review to expedite the process.

Related Resources